Medical/Pharmaceuticals
/C O R R E C T I O N -- Rayence/
In the news release, Rayence Breaks the Boundaries of Point-of-Care Imaging with the Launch of Integrated Portable X-ray Diagnostic Solutions 'Anywhere-M' and 'Anywhere-V', issued 18-Aug-2026 by Rayence over PR Newswire, we are advised by the company that the first paragraph has been updated and ...
2026-08-19 01:22
2134
Harbour BioMed Announces NMPA Approval of IND Application for HBM7004 for the Treatment of Advanced Solid Tumors
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Aug. 18, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other disease areas, today an...
2026-08-18 17:02
1393
WuXi XDC Achieves GMP Release of BCM3 Facility at Singapore Site, Enabling Global Clients with Professional Excellence
SINGAPORE, Aug. 18, 2026 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, today announced that its BCM3 dual-function production line for antibody i...
2026-08-18 12:03
2556
Enginprime Medical Closes $12M Series A Financing
Round exclusively led by Qiming Venture Partners; proceeds to fund China registration trial and overseas early-stage clinical development SHANGHAI and HANGZHOU, China, Aug. 17, 2026 /PRNewswire/ -- Enginprime Medical ("Enginprime" or the "Company"), a developer of percutaneous ventricular assist...
2026-08-18 08:00
2471
Connext Completes Enrollment in Phase 2 Trial of CNT201 in Dupuytren's Contracture
- All 56 planned participants enrolled approximately five months after first patient dosing - Topline Phase 2 data expected in late 2026 - Positive data could support expansion of CNT201 into Peyronie's disease and cellulite SEOUL, South Korea, Aug. 17, 2026 /PRNewswire/ -- Connext, a specialty...
2026-08-17 21:00
2122
U.S. Recruitment for Ohio State University Study Evaluating EmeTerm in Adults With Chronic Nausea and Vomiting
VANCOUVER, BC, Aug. 17, 2026 /PRNewswire/ -- Participant recruitment information for a clinical study being conducted at The Ohio State University has been publicly posted on ClinicalTrials.gov. The study, titled "Evaluating the Effect of Wearing a TENS Device in Nausea Relief," is also known as ...
2026-08-17 21:00
3718
Insilico Medicine Included in MSCI Global Small Cap Indexes, Gaining Capital Market Endorsement in Core Strengths
CAMBRIDGE, Mass., Aug. 17, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage drug discovery company powered by generative artificial intelligence (AI), announced that it will be included in MSCI Global Small Cap Indexes compiled by Morgan Stanley Capital Internatio...
2026-08-17 20:30
3727
Kelun-Biotech Announces 2026 Interim Results
CHENGDU, China, Aug. 17, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", Stock Code: 6990.HK) announces its unaudited consolidated results for the period ended 30 June 2026 (the "Reporting Period"). Key information is as follows: * Re...
2026-08-17 19:18
4269
SK bioscience Advances Development of Next-Generation Infectious Disease Prevention Platform with Global Phase 1b CTA Submission for RSV Preventive Antibody Candidate
* Phase 1b study will evaluate safety and pharmacokinetics of RSM01 in approximately 80 infants aged 2 weeks to 8 months * Company expands its global portfolio beyond vaccines into antibody-based preventive technologies * Growing global R&D network strengthens capabilities in next-generation...
2026-08-14 20:00
3753
/DISREGARD RELEASE: IASO Bio/
We are advised by IASO Bio that journalists and other readers should disregard the news release, IASO Biotechnology Announces Acquisition of Singapore-Based Cell Therapy Company MediSix Therapeutics, issued 13-Aug-2026 over PR Newswire, as the release contained erroneous information. ...
2026-08-14 13:30
3969
Dimora Medical's Sacrum Silicone Absorbent Soft Dressing Breaks into Amazon Wound Dressings Top 3
NEW YORK, Aug. 13, 2026 /PRNewswire/ -- Dimora Medical, a continuous innovator
in high-end medical care supplies, announced that its newly launchedDimora
Sacrum Silicone Absorbent Soft Dressing
2026-08-14 01:50
2654
Rhein Laser Unveils CELIORA®, a New Generation of Intelligent Red Light Therapy Beds
Five Wavelengths and 88,000 LED Chips Deliver the Industry's First Continuous, Dark-Line-Free Full-Body Red-Light Coverage MIAMI, Aug. 13, 2026 /PRNewswire/ -- Rhein Laser, a global developer of professional laser and photobiomodulation technologies, today announced the launch of the CELIORA® Re...
2026-08-13 21:10
2138
Coreline Soft and Optellum announce intent to collaborate to advance AI across the lung cancer pathway
Proposed collaboration would make Coreline Soft's FDA-cleared lung nodule
detection capability available through Optellum's LungOS® platform
OXFORD, England and SEOUL, South Korea, Aug. 13, 2026 /PRNewswire/ -- Optellum
2026-08-13 21:00
3549
Accro Bioscience to Present Phase Ib Data of AC-101, an Oral Selective RIPK2 Inhibitor, for Moderate-to-Severe UC at UEG Week 2026 in Barcelona
NEW YORK and SUZHOU, China, Aug. 13, 2026 /PRNewswire/ -- Accro Bioscience, a clinical-stage biotechnology company pioneering the development of novel therapeutics for immune mediated diseases, today announced that it will present efficacy and safety results from a Phase 1b proof-of-concept study...
2026-08-13 19:00
2397
PanTRKare™ Officially Approved as the Companion Diagnostic for VELMARTO® (Eratrectinib)
NANJING, China, Aug. 12, 2026 /PRNewswire/ -- August 6, the NMPA granted approval to Geneseeq's PanTRKare™ NTRK1/2/3 Gene Fusion Detection Kit as a companion diagnostic for VELMARTO® (Eratrectinib), a next‑generation highly selective TRK inhibitor independently developed by Vcare PharmaTech. The ...
2026-08-12 22:00
2965
RingConn Advances Wearable Health Research with New Study in Nature Portfolio Journal npj Digital Medicine
The study, "Large-scale bilateral cardiovascular monitoring via wearable rings," analyzes 97,559 valid ring-PPG samples from 1,810 participants, providing new insights into bilateral wearable sensing for cardiovascular monitoring. NEW YORK, Aug. 12, 2026 /PRNewswire/ -- A major step toward overc...
2026-08-12 22:00
4214
Insilico Medicine Nominates ISM0900, a Potent, AI-driven, Oral Lp(a) Inhibitor, as PCC for Management of Cardiovascular Risks
CAMBRIDGE, Mass., Aug. 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico"; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced the nomination of ISM0900, a potent, AI-driven, highly selective, orally available small molecule inh...
2026-08-12 20:30
2003
New Drug Application for LAE002 (afuresertib) Accepted by China's National Medical Products Administration
SHANGHAI, Aug. 11, 2026 /PRNewswire/ -- Laekna (2105.HK) announced today that the New Drug Application (NDA) for LAE002 (afuresertib) has been accepted by the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) for the treatment of patients with locally adv...
2026-08-12 08:45
2226
Datasea Announces FDA Registration and Device Listing for NeuroVibe Acoustic BCI Biofeedback System as a Class II 510(k)-Exempt Biofeedback Medical Device
BEIJING, Aug. 11, 2026 /PRNewswire/ -- Datasea Intelligent Technology Ltd. (NASDAQ: DTSS) ("Datasea" or the "Company"), a technology company focused on acoustic high-tech and AI multimodal digital solutions, today announced that Shuhai Jingwei (Shenzhen) Information Technology Co., Ltd. ("Shuhai ...
2026-08-11 21:01
2311
Insilico Medicine Announces 2026 Interim Earnings Conference Call Dates
CAMBRIDGE, Mass., Aug. 11, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico"; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced that it will hold conference calls to discuss its financial results for the six months ended June 30,...
2026-08-11 17:45
1965
Week's Top Stories
Most Reposted
Klook and Mastercard collaborate to enhance travelers' experiences across Asia Pacific
[Picked up by 310 media titles]
2026-08-27 10:25
AIMX Singapore 2026 Accelerates AI Deployment Through Catalysing Industry Innovation and Advancing Global Collaborations
[Picked up by 304 media titles]
2026-08-24 10:00
Henox and Nexusguard Announce Strategic Alliance at BATIC 2026 to Power and Protect the Next Generation of Digital Infrastructure
[Picked up by 297 media titles]
2026-08-25 10:00OGA 2026 Positions Kuala Lumpur as the Regional Marketplace for Southeast Asia's Energy Growth
[Picked up by 291 media titles]
2026-08-24 15:42
Rewarding Meetings Begin At Hyatt Regency Kuala Lumpur At KL Midtown
[Picked up by 289 media titles]
2026-08-25 07:00
Most Read
LightInTheBox to Report Second Quarter 2026 Financial Results on Wednesday, August 26, 2026
2026-08-21 19:00
11936